home / stock / bbva / bbva quote
Last: | $10.36 |
---|---|
Change Percent: | -1.78% |
Open: | $10.3 |
Close: | $10.36 |
High: | $10.36 |
Low: | $10.265 |
Volume: | 710,304 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.36 | $10.3 | $10.36 | $10.36 | $10.265 | 710,304 | 07-03-2024 |
$10.12 | $10.02 | $10.12 | $10.13 | $10.01 | 658,199 | 07-02-2024 |
$10.15 | $10.15 | $10.15 | $10.215 | $10.09 | 1,571,680 | 07-01-2024 |
$10.03 | $9.92 | $10.03 | $10.045 | $9.905 | 739,084 | 06-28-2024 |
$9.87 | $9.85 | $9.87 | $9.91 | $9.84 | 1,305,724 | 06-27-2024 |
$9.82 | $9.74 | $9.82 | $9.83 | $9.72 | 589,928 | 06-26-2024 |
$9.95 | $9.93 | $9.95 | $9.97 | $9.8501 | 886,710 | 06-25-2024 |
$10.06 | $10.02 | $10.06 | $10.105 | $10 | 1,950,689 | 06-24-2024 |
$9.74 | $9.77 | $9.74 | $9.84 | $9.7 | 1,957,915 | 06-21-2024 |
$10.03 | $9.93 | $10.03 | $10.1 | $9.93 | 1,092,602 | 06-20-2024 |
$9.89 | $9.82 | $9.89 | $9.92 | $9.8 | 1,181,006 | 06-19-2024 |
$9.89 | $9.82 | $9.89 | $9.92 | $9.8 | 1,181,006 | 06-18-2024 |
$9.82 | $9.73 | $9.82 | $9.85 | $9.67 | 858,627 | 06-17-2024 |
$9.64 | $9.52 | $9.64 | $9.7 | $9.475 | 2,024,212 | 06-14-2024 |
$9.82 | $10.03 | $9.82 | $10.03 | $9.77 | 1,243,424 | 06-13-2024 |
$10.13 | $10.12 | $10.13 | $10.19 | $10.08 | 1,070,322 | 06-12-2024 |
$10.28 | $10.34 | $10.28 | $10.34 | $10.23 | 1,509,236 | 06-11-2024 |
$10.5 | $10.48 | $10.5 | $10.51 | $10.445 | 676,087 | 06-10-2024 |
$10.63 | $10.73 | $10.63 | $10.75 | $10.62 | 1,128,214 | 06-07-2024 |
$10.65 | $10.56 | $10.65 | $10.7 | $10.54 | 1,487,429 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Banco Bilbao Vizcaya Argentaria S.A. Company Name:
BBVA Stock Symbol:
NYSE Market:
Banco Bilbao Vizcaya Argentaria S.A. Website:
2024-06-12 05:15:03 ET Exane BNP Paribas analyst issues UNDERPERFORM recommendation for BBVA on June 12, 2024 04:31AM ET. BBVA was trading at $10.28 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy...